| J9271 | Injection, pembrolizumab, 1 mg | 13,600 | $40 | $584.8K |
| J1930 | Injection, lanreotide, 1 mg | 3,240 | $40 | $142.6K |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 360 | $90 | $33.8K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 290 | $110 | $30.6K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 310 | $70 | $21.2K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 180 | $100 | $17.9K |
| 74177 | The provider performs computed tomography of the abdomen and pelvis with contrast material to diagnose the cause of abdominal or pelvic pain or other abnormalities of the internal organs. | 60 | $190 | $11K |
| J0185 | Injection, aprepitant, 1 mg | 9,360 | $1 | $9.4K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 40 | $160 | $6.1K |
| 96375 | Following the administration of a drug or other substance via intravenous, or IV, push, the provider sequentially infuses a different medication or medications, also via IV push. He administers the… | 490 | $10 | $5.8K |